SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-Q’ for 9/30/12 – ‘EX-101.CAL’

On:  Friday, 11/9/12, at 4:47pm ET   ·   For:  9/30/12   ·   Accession #:  1193125-12-463502   ·   File #:  0-19627

Previous ‘10-Q’:  ‘10-Q/A’ on 9/6/12 for 6/30/12   ·   Next:  ‘10-Q’ on 5/10/13 for 3/31/13   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/09/12  Biolase, Inc                      10-Q        9/30/12   62:4.8M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    438K 
 2: EX-31.1     Certification of Chief Executive Officer Pursuant   HTML     26K 
                to Rule 13A-14 and Rule 15D-14                                   
 3: EX-31.2     Certification of Chief Financial Officer Pursuant   HTML     26K 
                to Rule 13A-14 and Rule 15D-14                                   
 4: EX-32.1     Certification of Chief Executive Officer Pursuant   HTML     21K 
                to 18 U.S.C. 1350                                                
 5: EX-32.2     Certification of Chief Financial Officer Pursuant   HTML     21K 
                to 18 U.S.C. 1350                                                
42: R1          Document and Entity Information                     HTML     41K 
31: R2          Consolidated Balance Sheets                         HTML    141K 
40: R3          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
44: R4          Consolidated Statements of Comprehensive Loss       HTML    111K 
57: R5          Consolidated Statements of Cash Flows               HTML    155K 
34: R6          Basis of Presentation                               HTML     43K 
39: R7          Recent Accounting Pronouncements                    HTML     28K 
28: R8          Stock-Based Awards and Per Share Information        HTML     92K 
20: R9          Inventory                                           HTML     28K 
58: R10         Property, Plant, and Equipment                      HTML     35K 
46: R11         Intangible Assets and Goodwill                      HTML     47K 
45: R12         Accrued Liabilities and Deferred Revenue            HTML     56K 
50: R13         Lines of Credit and Other Borrowings                HTML     31K 
51: R14         Commitments and Contingencies                       HTML     28K 
49: R15         Segment Information                                 HTML     37K 
52: R16         Concentrations                                      HTML     24K 
41: R17         Income Taxes                                        HTML     25K 
43: R18         Non-Recurring Event                                 HTML     22K 
48: R19         Basis of Presentation (Policies)                    HTML    110K 
62: R20         Stock-Based Awards and Per Share Information        HTML     87K 
                (Tables)                                                         
54: R21         Inventory (Tables)                                  HTML     26K 
36: R22         Property, Plant, and Equipment (Tables)             HTML     32K 
47: R23         Intangible Assets and Goodwill (Tables)             HTML     41K 
38: R24         Accrued Liabilities and Deferred Revenue (Tables)   HTML     57K 
16: R25         Segment Information (Tables)                        HTML     30K 
55: R26         BASIS OF PRESENTATION - Additional Information      HTML     52K 
                (Detail)                                                         
59: R27         STOCK-BASED AWARDS AND PER SHARE INFORMATION -      HTML    114K 
                Additional Information (Detail)                                  
24: R28         STOCK-BASED AWARDS AND PER SHARE INFORMATION -      HTML     30K 
                Classification of Compensation Expense Associated                
                with Share-based Payments (Detail)                               
23: R29         STOCK-BASED AWARDS AND PER SHARE INFORMATION -      HTML     32K 
                Assumptions Used in Estimating Fair Value of Stock               
                Options Granted (Detail)                                         
26: R30         STOCK-BASED AWARDS AND PER SHARE INFORMATION -      HTML     65K 
                Summary of Option Activity under Stock Option                    
                Plans (Detail)                                                   
27: R31         STOCK-BASED AWARDS AND PER SHARE INFORMATION -      HTML     38K 
                Cash Proceeds Along with Fair Value Disclosures                  
                Related to Grants, Exercises and Vesting Options                 
                (Detail)                                                         
29: R32         STOCK-BASED AWARDS AND PER SHARE INFORMATION -      HTML     37K 
                Stock Repurchase Activities (Detail)                             
15: R33         INVENTORY - Inventories (Detail)                    HTML     31K 
53: R34         INVENTORY - Additional Information (Detail)         HTML     26K 
35: R35         PROPERTY, PLANT, AND EQUIPMENT - Summary of         HTML     37K 
                Property, Plant and Equipment (Detail)                           
37: R36         PROPERTY, PLANT, AND EQUIPMENT - Additional         HTML     42K 
                Information (Detail)                                             
18: R37         INTANGIBLE ASSETS AND GOODWILL - Additional         HTML     24K 
                Information (Detail)                                             
61: R38         INTANGIBLE ASSETS AND GOODWILL - Summary of         HTML     48K 
                Intangible Assets, Related Accumulated                           
                Amortization and Goodwill (Detail)                               
12: R39         ACCRUED LIABILITIES AND DEFERRED REVENUE -          HTML     51K 
                Components of Accrued Liabilities (Detail)                       
30: R40         ACCRUED LIABILITIES AND DEFERRED REVENUE - Changes  HTML     38K 
                in Initial Product Warranty Accrual and Expenses                 
                Under Initial and Extended Warranties (Detail)                   
56: R41         ACCRUED LIABILITIES AND DEFERRED REVENUE - Summary  HTML     40K 
                of Deferred Revenue (Detail)                                     
17: R42         ACCRUED LIABILITIES AND DEFERRED REVENUE -          HTML     26K 
                Additional Information (Detail)                                  
22: R43         LINES OF CREDIT AND OTHER BORROWINGS - Additional   HTML    118K 
                Information (Detail)                                             
25: R44         SEGMENT INFORMATION - Additional Information        HTML     31K 
                (Detail)                                                         
32: R45         SEGMENT INFORMATION - Summary of Net Revenue by     HTML     25K 
                Geographic Location (Detail)                                     
14: R46         CONCENTRATIONS - Additional Information (Detail)    HTML     37K 
19: R47         INCOME TAXES - Additional Information (Detail)      HTML     23K 
13: R48         NON-RECURRING EVENT - Additional Information        HTML     36K 
                (Detail)                                                         
60: XML         IDEA XML File -- Filing Summary                      XML     94K 
21: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    571K 
 6: EX-101.INS  XBRL Instance -- biol-20120930                       XML    973K 
 8: EX-101.CAL  XBRL Calculations -- biol-20120930_cal               XML    157K 
 9: EX-101.DEF  XBRL Definitions -- biol-20120930_def                XML    734K 
10: EX-101.LAB  XBRL Labels -- biol-20120930_lab                     XML   1.11M 
11: EX-101.PRE  XBRL Presentations -- biol-20120930_pre              XML    829K 
 7: EX-101.SCH  XBRL Schema -- biol-20120930                         XSD    167K 
33: ZIP         XBRL Zipped Folder -- 0001193125-12-463502-xbrl      Zip    132K 


‘EX-101.CAL’   —   XBRL Calculations — biol-20120930_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- RR Donnelley Xcelerate Taxonomy Calculation Linkbase, based on XBRL 2.1 http://www.rrdonnelley.com/ -->
<!-- Version: 6.20.1 -->
<!-- Round: 6 -->
<!-- Creation date: 2012-11-09T18:40:19Z -->
<!-- Copyright (c) 2005-2012 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DocumentDocumentandEntityInformation" roleURI="http://www.biolase.com/taxonomy/role/DocumentDocumentandEntityInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_StatementOfIncome" roleURI="http://www.biolase.com/taxonomy/role/StatementOfIncome"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://www.biolase.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureBasisOfPresentationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureStockBasedAwardsAndPerShareInformationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureStockBasedAwardsAndPerShareInformationClassificationOfCompensationExpenseAssociatedWithSharebasedPayments" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationClassificationOfCompensationExpenseAssociatedWithSharebasedPayments"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureStockBasedAwardsAndPerShareInformationAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureStockBasedAwardsAndPerShareInformationSummaryOfOptionActivityUnderStockOptionPlans" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationSummaryOfOptionActivityUnderStockOptionPlans"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureStockBasedAwardsAndPerShareInformationCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureStockBasedAwardsAndPerShareInformationStockRepurchaseActivities" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationStockRepurchaseActivities"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureInventoryInventories" roleURI="http://www.biolase.com/taxonomy/role/DisclosureInventoryInventories"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureInventoryAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureInventoryAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipment" roleURI="http://www.biolase.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipment"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosurePropertyPlantAndEquipmentAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureIntangibleAssetsAndGoodwillAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureIntangibleAssetsAndGoodwillSummaryOfIntangibleAssetsRelatedAccumulatedAmortizationAndGoodwill" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillSummaryOfIntangibleAssetsRelatedAccumulatedAmortizationAndGoodwill"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureAccruedLiabilitiesAndDeferredRevenueComponentsOfAccruedLiabilities" roleURI="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueComponentsOfAccruedLiabilities"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureAccruedLiabilitiesAndDeferredRevenueChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties" roleURI="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureAccruedLiabilitiesAndDeferredRevenueSummaryOfDeferredRevenue" roleURI="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueSummaryOfDeferredRevenue"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureAccruedLiabilitiesAndDeferredRevenueAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureSegmentInformationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureSegmentInformationSummaryOfNetRevenueByGeographicLocation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationSummaryOfNetRevenueByGeographicLocation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureConcentrationsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureConcentrationsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureIncomeTaxesAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#DisclosureNonRecurringEventAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureNonRecurringEventAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsAccountingChangesAndErrorCorrectionsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccountingChangesAndErrorCorrectionsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsConcentrationsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsConcentrationsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20120930.xsd#Role_NotesToFinancialStatementsNonRecurringEvents" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsNonRecurringEvents"/>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DocumentDocumentandEntityInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassified">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="us-gaap_CustomerDepositsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_StockholdersEquityExcludingTreasuryStock" xlink:label="biol_StockholdersEquityExcludingTreasuryStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredTaxAssetsNetNoncurrent" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1.1800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.1900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1.2000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1.2100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1.2800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LinesOfCreditCurrent" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_CustomerDepositsCurrent" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="1.1500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="biol_StockholdersEquityExcludingTreasuryStock" order="1.2600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_TreasuryStockValue" order="1.2700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_CommonStockValue" order="1.2200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.2300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1.2400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.2500" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfIncome">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_LicenseFeesAndRoyaltyRevenue" xlink:label="biol_LicenseFeesAndRoyaltyRevenue"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_NetCostOfRevenue" xlink:label="biol_NetCostOfRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_NonRecurringCostOfRevenue" xlink:label="biol_NonRecurringCostOfRevenue"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_NonRecurringRevenue" xlink:label="biol_NonRecurringRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_ProductsAndServicesRevenue" xlink:label="biol_ProductsAndServicesRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareBasic" order="1.1900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_SalesRevenueNet" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="biol_NetCostOfRevenue" order="1.0700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1.1600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_NetCostOfRevenue" xlink:to="us-gaap_CostOfRevenue" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_NetCostOfRevenue" xlink:to="biol_NonRecurringCostOfRevenue" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1.1700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.1800" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="1.1500" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1.1200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_ProductsAndServicesRevenue" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_NonRecurringRevenue" order="1.0200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_LicenseFeesAndRoyaltyRevenue" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.2000" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfCashFlowsIndirect">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_PaymentsOfStockRepurchaseCosts" xlink:label="biol_PaymentsOfStockRepurchaseCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_ProceedsFromStockOptionsAndWarrantsExercised" xlink:label="biol_ProceedsFromStockOptionsAndWarrantsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="1.0600" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="1.0700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="1.0800" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="biol_PaymentsOfStockRepurchaseCosts" order="1.0900" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants" order="1.1000" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="biol_ProceedsFromStockOptionsAndWarrantsExercised" order="1.1200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.0200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationClassificationOfCompensationExpenseAssociatedWithSharebasedPayments"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationSummaryOfOptionActivityUnderStockOptionPlans"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockBasedAwardsAndPerShareInformationStockRepurchaseActivities"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureInventoryInventories">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterials" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcess" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoods" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureInventoryAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipment">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0200" weight="-1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillSummaryOfIntangibleAssetsRelatedAccumulatedAmortizationAndGoodwill">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_FiniteLivedIntangibleAssetsImpairment" xlink:label="biol_FiniteLivedIntangibleAssetsImpairment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="biol_FiniteLivedIntangibleAssetsImpairment" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueComponentsOfAccruedLiabilities">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="us-gaap_AccruedInsuranceCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_AccruedSupportServices" xlink:label="biol_AccruedSupportServices"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="us-gaap_StandardProductWarrantyAccrual"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_StandardProductWarrantyAccrual" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="biol_AccruedSupportServices" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0700" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueSummaryOfDeferredRevenue">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrual" xlink:label="us-gaap_ExtendedProductWarrantyAccrual"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrualNoncurrent" xlink:label="us-gaap_ExtendedProductWarrantyAccrualNoncurrent"/>
<loc xlink:type="locator" xlink:href="biol-20120930.xsd#biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices" xlink:label="biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenue" xlink:to="biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_ExtendedProductWarrantyAccrual" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_ExtendedProductWarrantyAccrualNoncurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesAndDeferredRevenueAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationSummaryOfNetRevenueByGeographicLocation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureConcentrationsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureNonRecurringEventAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccountingChangesAndErrorCorrectionsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsAccruedLiabilitiesAndDeferredRevenueTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsConcentrationsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsNonRecurringEvents"> </calculationLink>
</linkbase>

Top
Filing Submission 0001193125-12-463502   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 2:12:49.1am ET